| Literature DB >> 19350267 |
Panagiotis Yannopoulos1, Panagiotis Theodoridis, Konstantinos Manes.
Abstract
OBJECTIVE: This study aimed to review and evaluate our experience in 750 patients, who underwent transhiatal esophagectomy (THE) and analyze our data. Special attention was paid to some strategies, which we developed in the course of time, regarding the postoperative management of these patients and formulation of improved guidelines. PATIENTS AND METHODS: This is a retrospective analysis of all THE operations performed between January 1981 until May 2007 in 750 patients: 60 patients (8%) had benign lesions, while 690 (92%) had malignant ones (5.2% of malignancies were located in the upper esophagus, 7.4% in the middle esophagus, 19% in the lower esophagus, and 68.4% at the cardioesophageal junction). THE and esophageal reconstruction were performed at the same operation in all patients. The stomach was our esophageal substitute of first choice with the colon and jejunum being acceptable alternatives in patients with prior gastric surgery and those necessitating synchronous gastrectomy for cancer invasion. A gastric tube was used as an esophageal substitute in 624 patients (83.2%), the whole stomach in 70 (9.4%), the colon in 43 (5.73%), and a jejunal loop in 13 (1.73%).Entities:
Mesh:
Year: 2009 PMID: 19350267 PMCID: PMC2687514 DOI: 10.1007/s00423-009-0488-6
Source DB: PubMed Journal: Langenbecks Arch Surg ISSN: 1435-2443 Impact factor: 3.445
Postsurgical TNM staging
| Postsurgical TNM staging | ||
|---|---|---|
| Stage | Number | Percentage |
| O | 14 | 2.02 |
| I | 42 | 6.08 |
| IIA | 120 | 17.39 |
| IIB | 73 | 10.58 |
| III | 404 | 58.55 |
| IV | 37 | 5.35 |
| Total | 690 | 100 |
Anastomotic leak rate according to period
| Anastomotic leak rate | ||||
|---|---|---|---|---|
| Period (years) | Patients ( | Leak rate (%) | ||
| Silent | Transient | Persistent | ||
| 1981–1990 | 255 | 11 | 9.4 | 20 |
| 1991–2000 | 345 | 13.3 | 5.5 | 11.6 |
| 2001–2007 | 150 | 16.6 | 4.76 | 6.35 |
Causes of hospital mortality among 750 patients
| Cause of death | No. of deaths |
|---|---|
| Malignant disease (690 patients) | 21 (3%) |
| Respiratory insufficiency | 6 |
| Pneumonia | 5 |
| Myocardial infarction | 4 |
| Sudden death/cardiac arrest | 3 |
| Sepsis | 3 |
| Benign disease (60 patients) | 1 (1.6%) |
| Myocardial infarction | 1 |
| Total | 22 (2.9%) |
Functional results
| Functional results after THE | ||
|---|---|---|
| Cervical dysphagia | No | 68% |
| Mild with no treatment | 16% | |
| Periodic—occasional dilatation | 10.9% | |
| Severe | 5.1% | |
| Regurgitation | No | 63.8% |
| Mild after eating | 31.3% | |
| Severe | 4.3% | |
| Severe with aspiration | 0.6% | |
| Overall functional results | Excellent | 47% |
| Good | 36.2% | |
| Fair | 11.7% | |
| Poor | 5.1% | |
Fig. 1Stage-dependent Kaplan–Meier actuarial survival curves
Survival rate after THE by tumor stage
| TNM stage | 2-year survival (%) | 5-year survival (%) |
|---|---|---|
| Ο | 89% | 83.3% |
| Ι | 85% | 61% |
| ΙΙΑ | 48.7% | 23.3% |
| ΙΙΒ | 49% | 28.1% |
| ΙΙΙ | 33% | 9.1% |
| ΙV | 4% | 0% |